Aspirin use tied to age-related vision loss
Taking at least one aspirin every week is linked to the development of age-related vision loss, according to an Australian study that looked at information collected over 15 years.
More than 100 billion aspirin tablets are consumed every year, commonly in the prevention of heart attacks or strokes.
In 2011, a European study found that seniors who took a daily aspirin were twice as likely to develop vision loss such as macular degeneration, compared with those who did not — prompting new study leader Jie Jin Wang into trying to confirm its findings.
Overall, Wang, from the University of Sydney, and her colleagues had information on 2,389 people older than 45. Of those, 257 said they took at least one aspirin every week.
By the end of the study, 63 people had developed so-called wet macular degeneration, the most severe form. A total of 5.8 percent of regular aspirin users developed the vision loss, compared with 2.3 percent of people who did not regularly take aspirin.
“Regular aspirin use is associated with increased risk of incident neovascular (wet) age-related macular degeneration, independent of a history of cardiovascular disease and smoking,” Wang and her colleagues wrote.
They warned, though, that there's still not enough evidence to say taking aspirin leads to the condition.
But in a commentary published with the study, Sanjay Kaul and George Diamond cautioned that the study had limitations, noting that previous studies had found mixed results when looking at aspirin use and vision loss.
They wrote that the evidence was not convincing enough for doctors to change how they prescribe aspirin, especially with its benefits in preventing heart attack and stroke.
“In the final analysis, decisions about aspirin use are best made by balancing the risks against the benefit in context of each individual's medical history and value judgment,” they wrote.
Wang agreed that the findings are not strong enough to support a change in clinical practice, but she said some doctors may want to keep a closer watch on patients at higher risk for macular degeneration who are using aspirin.
Show commenting policy
TribLive commenting policy
- Blizzard-stricken East digs out amid forecast 2nd-guessing
- House passes bill aimed at expediting natural gas exports
- Pittsburgh travelers feel effects of Northeast blizzard
- Medicare payments to tie doctor, hospital payments to quality rather than volume of care
- New York father kils 3 generations of family, himself
- Ramping up e-cigarette voltage may be more hazardous to health
- Orcas could land on endangered list
- VA plans major structure changes; Pittsburgh’s fate as regional HQ remains unclear
- House sales tax proposal criticized as attack on states’ rights
- Wisconsin’s Walker takes first step toward possible run in 2016
- Marine Corps’ general outlines priorities, vision